ASPIRE BIOPHARMA HOLDINGS IN (ASBP) Stock Price, Forecast & Analysis

USA • Nasdaq • NASDAQ:ASBP • US7389202067

1.35 USD
-0.06 (-4.26%)
At close: Feb 11, 2026
1.29 USD
-0.06 (-4.44%)
Pre-Market: 2/12/2026, 5:11:01 AM

ASBP Key Statistics, Chart & Performance

Key Statistics
Market Cap145.10M
Revenue(TTM)1.90K
Net Income(TTM)-28.70M
Shares107.48M
Float92.47M
52 Week High198
52 Week Low1.21
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-1.65
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2022-02-18
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
ASBP short term performance overview.The bars show the price performance of ASBP in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

ASBP long term performance overview.The bars show the price performance of ASBP in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ASBP is 1.35 USD. In the past month the price decreased by -57.71%.

ASPIRE BIOPHARMA HOLDINGS IN / ASBP Daily stock chart

ASBP Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
ASBP Full Technical Analysis Report

ASBP Financial Highlights

Over the last trailing twelve months ASBP reported a non-GAAP Earnings per Share(EPS) of -1.65. The EPS decreased by -282.24% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1194.47%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%46.57%
Sales Q2Q%N/A
EPS 1Y (TTM)-282.24%
Revenue 1Y (TTM)N/A
ASBP financials

ASBP Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
ASBP Analyst EstimatesASBP Analyst Ratings

ASBP Ownership

Ownership
Inst Owners2.91%
Ins Owners13.96%
Short Float %N/A
Short Ratio1.05
ASBP Ownership

ASBP Latest News, Press Relases and Analysis

All ASBP news

ASBP Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO30.25959.759B
JNJ JOHNSON & JOHNSON20.67580.304B
MRK MERCK & CO. INC.22.05296.13B
PFE PFIZER INC9.23157.665B
BMY BRISTOL-MYERS SQUIBB CO9.85122.002B
ZTS ZOETIS INC18.7456.704B
RPRX ROYALTY PHARMA PLC- CL A8.5325.543B
VTRS VIATRIS INC6.3818.578B
ELAN ELANCO ANIMAL HEALTH INC24.5912.774B
AXSM AXSOME THERAPEUTICS INC227.379.387B

About ASBP

Company Profile

ASBP logo image Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.

Company Info

ASPIRE BIOPHARMA HOLDINGS IN

194 Candelaro Drive, #233

Humacao NEW YORK PR

Employees: 0

ASBP Company Website

ASBP Investor Relations

Phone: 15617048527

ASPIRE BIOPHARMA HOLDINGS IN / ASBP FAQ

What does ASBP do?

Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engages in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.


What is the current price of ASBP stock?

The current stock price of ASBP is 1.35 USD. The price decreased by -4.26% in the last trading session.


Does ASBP stock pay dividends?

ASBP does not pay a dividend.


How is the ChartMill rating for ASPIRE BIOPHARMA HOLDINGS IN?

ASBP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


What is the employee count for ASBP stock?

ASPIRE BIOPHARMA HOLDINGS IN (ASBP) currently has 0 employees.


What is the ownership structure of ASPIRE BIOPHARMA HOLDINGS IN (ASBP)?

You can find the ownership structure of ASPIRE BIOPHARMA HOLDINGS IN (ASBP) on the Ownership tab.